Advances in the Management of Moderate-to-Severe Atopic Dermatitis
Host: Peter A. Lio, MD
\n\n Guest: Eric Simpson, MD, MCR
\n\n Guest: Mark Boguniewicz, MD
\n\n\n \n
Please note: This activity is no longer available for continuing education credit.
\u201cI begged my doctor for something else \u2013 there had to be something else,\u201d Pam.
For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of the several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam\u2019s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.